BIOCODEX
BIOCODEX
Status:
Active
Similar Organizations
C3 International
C3 International is a biopharmaceutical company.
Infarmatik
Infarmatik is a Pharmaceutical company.
Lederle International
Lederle International is a pharmaceuticals company
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-02-05 | MaaT Pharma | Biocodex investment in Series B - MaaT Pharma | 18 M EUR |
| 2018-07-06 | Exeliom | Biocodex investment in Series A - Exeliom | 7 M EUR |
More informations about "Biocodex"
Biocodex in Canada
Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its products and expanding its geographical footprint. We …See details»
About Us - Biocodex.com
Biocodex is a family-owned pharmaceutical company that provides innovative healthcare solutions to patients in more than 100 countries worldwide. Founded in 1953 to market the …See details»
Biocodex Canada - Biocodex.com
Biocodex develops, manufactures and distributes world-class pharmaceutical products and health solutions for patients in more than 120 countries. Focusing on three main pillars (microbiota mission, orphan drugs and women’s health), …See details»
Home Page - Biocodex.com
Biocodex is a family-owned company founded more than 60 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded its expertise in gut microbiota, evolving from …See details»
Biocodex at a glance
Biocodex at a glance. Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. Present in more than 100 countries, …See details»
BIOCODEX - Crunchbase Company Profile & Funding
Biocodex is an independent multinational pharmaceutical company built on high-standards science and manufacturing, with six decades of proven success. Founded in 1953, the …See details»
Biocodex - Crunchbase Investor Profile & Investments
PR Newswire — Biocodex to present new data at the American Epilepsy Society (AES) 2024 Annual Meeting Funding Round • May 15, 2024 MaaT Pharma raised €18,200,000 / Post Ipo …See details»
Our development - Biocodex USA
Biocodex develops, manufactures and distributes world-class pharmaceutical products and health solutions for patients in more than 120 countries. Focusing on three main pillars (microbiota mission, orphan drugs and women’s health), …See details»
Our mission - Biocodex.com
Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. Biocodex’s mission As an international pharmaceutical company, …See details»
Our science - Biocodex.com
Acquired by Biocodex in 2014, Ferlux operates a 2-hectare plant near Clermont-Ferrand in the South of France. As a pioneer in the science of polyphenols and the producer of the only …See details»
International - Biocodex USA
Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its …See details»
Biocodex Microbiota Foundation Invites Canadian Academics and ...
Sep 30, 2024 Biocodex Canada. MONTREAL, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to …See details»
Biocodex Microbiota Foundation Invites Canadian Academics
Sep 30, 2024 The Biocodex Microbiota Foundation is a non-profit, general interest organization that supports research into microbiota and their interaction with various pathologies. Both …See details»
Biocodex Company Profile - Office Locations, Competitors ... - Craft
Biocodex has 5 employees across 11 locations and €310 m in annual revenue in FY 2018. See insights on Biocodex including office locations, competitors, revenue, financials, executives, …See details»
Our governance - Biocodex.com
Biocodex is a family-owned company founded 70 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded its …See details»
International - Biocodex.com
Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its …See details»
International - biocodex.fi
Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its …See details»
Our focus - Biocodex.com
Biocodex is committed to improving the health and well-being of patients and consumers around the world at every stage of their lives, focusing on three areas of expertise: microbiota care, …See details»
Our heritage - Biocodex USA
Biocodex’s unique strain. In 1953, Biocodex acquired the rights to Henri Boulard’s yeast strain and fermentation process, and in 1961, the company registered lyophilized Saccharomyces …See details»